Back
Share

Stem Cell Reviews

Stem Cell Reviews is not currently indexed in Scopus. Published by Humana Press Inc..

ISSN 1550-8943Verify ISSN ↗1558-6804Verify ISSN ↗

Publisher: Humana Press Inc.

Scopus · Inactive
0
Indexed in
major indexes

Cost to publish: About US$4,390 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free

Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
Not listed in Web of Science.
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.

Is Stem Cell Reviews indexed in Scopus? No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2005–2008).

What is the impact factor of Stem Cell Reviews? Stem Cell Reviews has no Journal Impact Factor — JIF is published only for Web of Science SCIE and SSCI titles — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.

Is Stem Cell Reviews in Web of Science? No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).

Is Stem Cell Reviews open access? No — it is not registered as an open-access journal in DOAJ or Scopus.

Impact & reach — open metrics via OpenAlex

111
h-index
4.27
2-yr mean citations
1,415
i10-index
2,364
works indexed
69,890
total citations
Papers published per year
02505002017: 87 papers8720172018: 71 papers7120182019: 72 papers7220192020: 148 papers14820202021: 211 papers21120212022: 188 papers18820222023: 179 papers17920232024: 159 papers15920242025: 208 papers20820252026: 195 papers so far1952026*

Stem Cell Reviews published 208 papers in 2025; its busiest recent year was 2021 with 211. 2026* is the year so far.

Main topics
Mesenchymal stem cell researchPluripotent Stem Cells ResearchTissue Engineering and Regenerative MedicineCRISPR and Genetic Engineering

h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-09-24.

Integrity signals — indicators, not proof of misconduct

  • Scopus statusInactive — coverage ended 2008
  • Retracted papers 1 · 0.4 per 1,000 papers

Retractions and authorship from OpenAlex; Scopus status from the Scopus source list. A signal marks something to look at more closely; it is not a finding against the journal.

Official sources & links

Scopus source ↗ ISSN Portal · 1550-8943 ↗ISSN Portal · 1558-6804 ↗

Related journals

← Back to Journal Finder

Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.